Among female-specific cancers worldwide, ovarian cancer is the leading cause of death from gynaecologic malignancy in the western world. Treatments available today are often associated with side effects that impact quality of life. Therefore, there is an important need to establish novel targeted therapies and their routes of administration to improve clinical outcomes and tolerability in ovarian cancer treatment.
Sources: NIH.gov
Approved treatments
No marketed radiotherapeutics available for this indication yet.
About female cancer
- Cancer Facts for Women – American Cancer Society
- Gynecologic Cancers – Centers for Disease Control and Prevention (CDC)
- Women’s Cancers – International Gynecologic Cancer Society (IGCS)
- Ovarian Cancer – Ovarian Cancer Research Alliance (OCRA)
Patient associations
Worldwide: Facing Our Risk of Cancer Empowered (FORCE), Foundation for Women’s Cancer, Bright Pink, The International Ovarian Cancer Connection
North America: SHARE Cancer Support (USA)